Cargando…
The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
Background. Lanthanum carbonate and sevelamer carbonate are non-calcium-based phosphate binders used to manage hyperphosphataemia in patients with chronic kidney disease (CKD). Patients with CKD may require intravenous or oral active vitamin D. We investigated the effects of lanthanum carbonate and...
Autores principales: | Pierce, David, Hossack, Stuart, Poole, Lynne, Robinson, Antoine, Van Heusen, Heather, Martin, Patrick, Smyth, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084439/ https://www.ncbi.nlm.nih.gov/pubmed/20921291 http://dx.doi.org/10.1093/ndt/gfq598 |
Ejemplares similares
-
Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate
por: Lindley, Elizabeth, et al.
Publicado: (2008) -
Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023) -
Lanthanum Carbonate Reduces Urine Phosphorus Excretion: Evidence of High-Capacity Phosphate Binding
por: Pennick, Michael, et al.
Publicado: (2012) -
Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
por: Makowka, Agnieszka, et al.
Publicado: (2021) -
Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure
por: Phan, Olivier, et al.
Publicado: (2015)